Optimising Primary Therapy in Primary Biliary Cholangitis 

• Study stage: Set-up
• Sponsor: The Newcastle upon Tyne Hospitals NHS Foundation Trust
• Funder: NIHR-EME Programme/Intercept Pharmaceuticals
• Therapeutic area: Liver Disease
• Type of study: CTIMP

Aim:

Primary Outcome:

• Population: Adults
• Phase: IIb
• Design: RCT (double blind)
• Setting: Secondary care
• Planned Sample Size: 106